ヒトオルガノイドの世界市場、2024～2028年

ヒトオルガノイド市場、2024～2028年

ヒトオルガノイド市場は2023～2028年に11億7,850万米ドル、予測期間中のCAGRは16.81％で成長すると予測されます。当レポートでは、ヒトオルガノイド市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、従来の手法に対するヒトオルガノイドの優位性、疾患モデリングのためのヒトオルガノイドの普及拡大、感染症のためのヒトオルガノイドの普及拡大です。

本調査では、今後数年間のヒトオルガノイド市場成長を促進する主要要因の1つとして、ベンダーが新製品の発売を重視するようになっていることを挙げています。また、バイオプリンティング技術の出現や、医療の個別化開拓におけるヒトオルガノイドの応用拡大も、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023年
• 市場の展望 2023～2028年

第4章 市場規模実績

• ヒトオルガノイドの世界市場 2018～2022年
• エンドユーザー別セグメント分析 2018～2022年
• 地域別セグメント分析 2018～2022年
• 国別セグメント分析 2018～2022年

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：エンドユーザー別

• 市場セグメンテーション
• 比較：エンドユーザー別
• 製薬・バイオテクノロジー企業：市場規模と予測 2023～2028年
• 委託研究機関：市場規模と予測 2023～2028年
• 学術研究機関：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• 市場機会：エンドユーザー別

第7章 顧客情勢

• 顧客情勢概要

第8章 地域別情勢

• 地域別セグメンテーション
• 比較：地域別
• 北米：市場規模と予測 2023～2028年
• 欧州：市場規模と予測 2023～2028年
• アジア：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• 米国：市場規模と予測 2023～2028年
• ドイツ：市場規模と予測 2023～2028年
• 英国：市場規模と予測 2023～2028年
• カナダ：市場規模と予測 2023～2028年
• 中国：市場規模と予測 2023～2028年
• 市場機会：地域情勢別

第9章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第10章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第11章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• BioIVT LLC
• Cellesce Ltd.
• Corning Inc.
• DefiniGEN Ltd.
• Emulate Inc.
• Hubrecht Organoid Technology
• Merck KGaA
• Organoid Therapeutics
• STEMCELL Technologies Inc.
• ZenBio Inc.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Parent Market
• Exhibits10: Data Table on - Parent Market
• Exhibits11: Market characteristics analysis
• Exhibits12: Value Chain Analysis
• Exhibits13: Offerings of companies included in the market definition
• Exhibits14: Market segments
• Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Historic Market Size - Data Table on Global Human Organoids Market 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on End-user - Market share 2023-2028 (%)
• Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by End-user
• Exhibits33: Data Table on Comparison by End-user
• Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits50: Market opportunity by End-user ($ million)
• Exhibits51: Data Table on Market opportunity by End-user ($ million)
• Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits55: Chart on Geographic comparison
• Exhibits56: Data Table on Geographic comparison
• Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits93: Market opportunity By Geographical Landscape ($ million)
• Exhibits94: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits95: Impact of drivers and challenges in 2023 and 2028
• Exhibits96: Overview on criticality of inputs and factors of differentiation
• Exhibits97: Overview on factors of disruption
• Exhibits98: Impact of key risks on business
• Exhibits99: Companies covered
• Exhibits100: Matrix on companies position and classification
• Exhibits101: BioIVT LLC - Overview
• Exhibits102: BioIVT LLC - Product / Service
• Exhibits103: BioIVT LLC - Key news
• Exhibits104: BioIVT LLC - Key offerings
• Exhibits105: Cellesce Ltd. - Overview
• Exhibits106: Cellesce Ltd. - Product / Service
• Exhibits107: Cellesce Ltd. - Key offerings
• Exhibits108: Corning Inc. - Overview
• Exhibits109: Corning Inc. - Business segments
• Exhibits110: Corning Inc. - Key news
• Exhibits111: Corning Inc. - Key offerings
• Exhibits112: Corning Inc. - Segment focus
• Exhibits113: DefiniGEN Ltd. - Overview
• Exhibits114: DefiniGEN Ltd. - Product / Service
• Exhibits115: DefiniGEN Ltd. - Key offerings
• Exhibits116: Emulate Inc. - Overview
• Exhibits117: Emulate Inc. - Product / Service
• Exhibits118: Emulate Inc. - Key offerings
• Exhibits119: Hubrecht Organoid Technology - Overview
• Exhibits120: Hubrecht Organoid Technology - Product / Service
• Exhibits121: Hubrecht Organoid Technology - Key offerings
• Exhibits122: Merck KGaA - Overview
• Exhibits123: Merck KGaA - Business segments
• Exhibits124: Merck KGaA - Key news
• Exhibits125: Merck KGaA - Key offerings
• Exhibits126: Merck KGaA - Segment focus
• Exhibits127: Organoid Therapeutics - Overview
• Exhibits128: Organoid Therapeutics - Product / Service
• Exhibits129: Organoid Therapeutics - Key offerings
• Exhibits130: STEMCELL Technologies Inc. - Overview
• Exhibits131: STEMCELL Technologies Inc. - Product / Service
• Exhibits132: STEMCELL Technologies Inc. - Key offerings
• Exhibits133: ZenBio Inc. - Overview
• Exhibits134: ZenBio Inc. - Product / Service
• Exhibits135: ZenBio Inc. - Key offerings
• Exhibits136: Inclusions checklist
• Exhibits137: Exclusions checklist
• Exhibits138: Currency conversion rates for US$
• Exhibits139: Research methodology
• Exhibits140: Information sources
• Exhibits141: Data validation
• Exhibits142: Validation techniques employed for market sizing
• Exhibits143: Data synthesis
• Exhibits144: 360 degree market analysis
• Exhibits145: List of abbreviations

Human Organoids Market 2024-2028

The human organoids market is forecasted to grow by USD 1178.5 mn during 2023-2028, accelerating at a CAGR of 16.81% during the forecast period. The report on the human organoids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by advantages of human organoids over traditional methods, increasing prevalence of human organoids for disease modeling, and growing prevalence of human organoids for infectious diseases.

Technavio's human organoids market is segmented as below:

By End-user

• Pharmaceutical and biotechnology companies
• Contract research organizations
• Academic and research institutes
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increasing focus of vendors on new product launches as one of the prime reasons driving the human organoids market growth during the next few years. Also, emergence of bioprinting technology and growing application of human organoids in medicine personalized development will lead to sizable demand in the market.

The report on the human organoids market covers the following areas:

• Human organoids market sizing
• Human organoids market forecast
• Human organoids market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human organoids market vendors that include BICO Group AB, BioIVT LLC, Biopredic International, Cellesce Ltd., CN Bio Innovations Ltd., Corning Inc., DefiniGEN Ltd., Emulate Inc., Hubrecht Organoid Technology, InSphero AG, Kirkstall Ltd., Merck KGaA, MIMETAS BV, Organoid Therapeutics, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., United Therapeutics Corp., and ZenBio Inc.. Also, the human organoids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Human Organoids Market 2018 - 2022
  • Historic Market Size - Data Table on Global Human Organoids Market 2018 - 2022 ($ million)
• 4.2 End-user segment analysis 2018 - 2022
  • Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

• 6.1 Market segments
  • Chart on End-user - Market share 2023-2028 (%)
  • Data Table on End-user - Market share 2023-2028 (%)
• 6.2 Comparison by End-user
  • Chart on Comparison by End-user
  • Data Table on Comparison by End-user
• 6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
  • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
  • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
  • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
• 6.4 Contract research organizations - Market size and forecast 2023-2028
  • Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million)
  • Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million)
  • Chart on Contract research organizations - Year-over-year growth 2023-2028 (%)
  • Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%)
• 6.5 Academic and research institutes - Market size and forecast 2023-2028
  • Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
  • Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million)
  • Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
  • Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)
  • Data Table on Market opportunity by End-user ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 8.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 BioIVT LLC
  • BioIVT LLC - Overview
  • BioIVT LLC - Product / Service
  • BioIVT LLC - Key news
  • BioIVT LLC - Key offerings
• 11.4 Cellesce Ltd.
  • Cellesce Ltd. - Overview
  • Cellesce Ltd. - Product / Service
  • Cellesce Ltd. - Key offerings
• 11.5 Corning Inc.
  • Corning Inc. - Overview
  • Corning Inc. - Business segments
  • Corning Inc. - Key news
  • Corning Inc. - Key offerings
  • Corning Inc. - Segment focus
• 11.6 DefiniGEN Ltd.
  • DefiniGEN Ltd. - Overview
  • DefiniGEN Ltd. - Product / Service
  • DefiniGEN Ltd. - Key offerings
• 11.7 Emulate Inc.
  • Emulate Inc. - Overview
  • Emulate Inc. - Product / Service
  • Emulate Inc. - Key offerings
• 11.8 Hubrecht Organoid Technology
  • Hubrecht Organoid Technology - Overview
  • Hubrecht Organoid Technology - Product / Service
  • Hubrecht Organoid Technology - Key offerings
• 11.9 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
• 11.10 Organoid Therapeutics
  • Organoid Therapeutics - Overview
  • Organoid Therapeutics - Product / Service
  • Organoid Therapeutics - Key offerings
• 11.11 STEMCELL Technologies Inc.
  • STEMCELL Technologies Inc. - Overview
  • STEMCELL Technologies Inc. - Product / Service
  • STEMCELL Technologies Inc. - Key offerings
• 11.12 ZenBio Inc.
  • ZenBio Inc. - Overview
  • ZenBio Inc. - Product / Service
  • ZenBio Inc. - Key offerings

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
  • 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations